Impact of SARS-CoV2 infection on gut microbiota dysbiosis

Abstract

The composition and function of the gut microbiota constantly influence health. Disruptions in this delicate balance, termed gut microbiota dysbiosis, have been implicated in various adverse health events. As the largest global epidemic since 1918, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had devastating consequences. While the primary impact of Corona Virus Disease 2019 (COVID-19) has been on the respiratory system, a growing body of research has unveiled the significant involvement of the gastrointestinal tract as well. Emerging evidence underscores notable alterations in the gut microbiome of COVID-19 patients. In addition, the gut microbiome is also characterized by an abundance of opportunistic pathogens, which is related to disease manifestations of COVID-19 patients. The intricate bidirectional interaction between the respiratory mucosa and the gut microbiota, known as the gut-lung axis, emerges as a crucial player in the pathological immune response triggered by SARS-CoV-2. Here, we discuss microbiota-based gut characteristics of COVID-19 patients and the long-term consequences of gut microbiota dysregulation. These insights could potentially transform the development of long-term interventions for COVID-19, offering hope for improved outcomes and enhanced patient recovery.

Keywords

COVID-19 / gut microbiome / gut-lung axis / inflammation / immunity

References

[1] Fan Y.Gut microbiota in human metabolic health and disease.Nat Rev Microbiol2021;19:55-71

[2] Lee JY,Bäumler AJ.The microbiome and gut homeostasis.Science2022;377:eabp9960

[3] Sencio V,Trottein F.The lung-gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes.Mucosal Immunol2021;14:296-304

[4] Arpaia N,Fan X.Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation.Nature2013;504:451-5

[5] He F,Li W.Coronavirus disease 2019: what we know?.J Med Virol2020;92:719-25

[6] Zuo T,Lui GCY.Alterations in gut microbiota of patients with COVID-19 during time of hospitalization.Gastroenterology2020;159:944-55.e8

[7] Gomaa EZ.Human gut microbiota/microbiome in health and diseases: a review.Antonie Van Leeuwenhoek2020;113:2019-40

[8] Wu Y,Jiang G.Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization.NPJ Biofilms Microbiomes2021;7:61

[9] He F,Xue K.Fecal multi-omics analysis reveals diverse molecular alterations of gut ecosystem in COVID-19 patients.Anal Chim Acta2021;1180:338881

[10] Zuo T,Zhang F.Alterations in fecal fungal microbiome of patients with COVID-19 during time of hospitalization until discharge.Gastroenterology2020;159:1302-10.e5

[11] Shen Y,Zhang D.Dynamic alterations in the respiratory tract microbiota of patients with COVID-19 and its association with microbiota in the gut.Adv Sci2022;9:e2200956

[12] Gu S,Wu Z.Alterations of the gut microbiota in patients with coronavirus disease 2019 or H1N1 influenza.Clin Infect Dis2020;71:2669-78

[13] Zhang F,Zuo T.Prolonged impairment of short-chain fatty acid and L-isoleucine biosynthesis in gut microbiome in patients with COVID-19.Gastroenterology2022;162:548-61.e4

[14] Lv W,Shao J,Xia L.Causal relationships between short-chain fatty acids and L-isoleucine biosynthesis and susceptibility and severity of COVID-19: evidence from Mendelian randomization.J Infect2023;87:e16-8

[15] Lv L,Chen Y.The faecal metabolome in COVID-19 patients is altered and associated with clinical features and gut microbes.Anal Chim Acta2021;1152:338267

[16] Yelin D,Yahav D,Bruchfeld J.Long COVID-19-it’s not over until?.Clin Microbiol Infect2021;27:506-8

[17] Vestad B,Lerum TV.Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations.J Intern Med2022;291:801-12

[18] Cui GY,Zeng ZH.Characterization of oral and gut microbiome and plasma metabolomics in COVID-19 patients after 1-year follow-up.Mil Med Res2022;9:32

[19] Su Q,Liu Q,Ng SC.Post-acute COVID-19 syndrome and gut dysbiosis linger beyond 1 year after SARS-CoV-2 clearance.Gut2023;72:1230-2

[20] Dumas A,Poquet Y,Neyrolles O.The role of the lung microbiota and the gut-lung axis in respiratory infectious diseases.Cell Microbiol2018;20:e12966

[21] Wang J,Wei H,Sun R.Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation.J Exp Med2014;211:2397-410

[22] Groves HT,Moffatt MF,Tregoning JS.Respiratory viral infection alters the gut microbiota by inducing inappetence.mBio2020;11:e03236-19

[23] Merad M.Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages.Nat Rev Immunol2020;20:355-62

[24] Cerf-Bensussan N.The immune system and the gut microbiota: friends or foes?.Nat Rev Immunol2010;10:735-44

[25] Liang W,Rao S.Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus.Gut2020;69:1141-3

[26] Qi F,Zhang S.Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses.Biochem Biophys Res Commun2020;526:135-40

[27] Hoffmann M,Schroeder S.SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor.Cell2020;181:271-80.e8

[28] Walls AC,Tortorici MA,McGuire AT.Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein.Cell2020;183:1735

[29] Lin L,Zhang Z.Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection.Gut2020;69:997-1001

[30] Jiang X,Zou Z,Chen C.Asymptomatic SARS-CoV-2 infected case with viral detection positive in stool but negative in nasopharyngeal samples lasts for 42 days.J Med Virol2020;92:1807-9

[31] Bradley BT,Johnston R.Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series.Lancet2020;396:320-32

[32] Jiao L,Xu J.The gastrointestinal tract is an alternative route for SARS-CoV-2 infection in a nonhuman primate model.Gastroenterology2021;160:1647-61

[33] Lamers MM,van der Vaart J.SARS-CoV-2 productively infects human gut enterocytes.Science2020;369:50-4

[34] Katz-Agranov N.Autoimmunity and COVID-19 - The microbiotal connection.Autoimmun Rev2021;20:102865

[35] de Oliveira AP, Lopes ALF, Pacheco G, de Sá Guimarães Nolêto IR, Nicolau LAD, Medeiros JVR. Premises among SARS-CoV-2, dysbiosis and diarrhea: walking through the ACE2/mTOR/autophagy route.Med Hypotheses2020;144:110243

[36] Patel P.Gut microbiome composition is associated with COVID-19 disease severity.Gastroenterology2021;161:722-4

[37] Rawson TM,Zhu N.Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing.Clin Infect Dis2020;71:2459-68

[38] Chen N,Dong X.Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.Lancet2020;395:507-13

[39] Cox MJ,Bogaert D.Co-infections: potentially lethal and unexplored in COVID-19.Lancet Microbe2020;1:e11

[40] Martins-Filho PR,Santos VS.Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data.Eur J Intern Med2020;76:97-9

[41] Li J,Handberg EM,Raizada MK.Butyrate regulates COVID-19-relevant genes in gut epithelial organoids from normotensive rats.Hypertension2021;77:e13-6

[42] Liu XF,Liao YT.Regulation of short-chain fatty acids in the immune system.Front Immunol2023;14:1186892

[43] Fan L,Wang Y.Gut microbiota bridges dietary nutrients and host immunity.Sci China Life Sci2023;66:2466-514

[44] Zuo T,Zhang F.Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19.Gut2021;70:276-84

[45] Stefan KL,Iwasaki A.Commensal microbiota modulation of natural resistance to virus infection.Cell2020;183:1312-24.e10

[46] Tang L,Gong Y.Clinical significance of the correlation between changes in the major intestinal bacteria species and COVID-19 severity.Engineering2020;6:1178-84

[47] Ma N,Johnston LJ.Host-microbiome interactions: the aryl hydrocarbon receptor as a critical node in tryptophan metabolites to brain signaling.Gut Microbes2020;11:1203-19

[48] Tsay JCJ,Sulaiman I.Lower airway dysbiosis affects lung cancer progression.Cancer Discov2021;11:293-307

[49] Dhar D.Gut microbiota and Covid-19- possible link and implications.Virus Res2020;285:198018

[50] Mendes de Almeida V,Ricci MF.Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID symptoms.Gut Microbes2023;15:2249146

[51] Lau HCH,Yu J.Targeting the gut microbiota in coronavirus disease 2019: hype or hope?.Gastroenterology2022;162:9-16

[52] Troisi J,Pujolassos Tanyà M,Landolfi A.COVID-19 and the gastrointestinal tract: source of infection or merely a target of the inflammatory process following SARS-CoV-2 infection?.World J Gastroenterol2021;27:1406-18

[53] Wu D,Dong S.Mutual interaction of microbiota and host immunity during health and diseases.Biophys Rep2021;7:326-40

[54] Mozaffari SA,Mousavi E.SARS-CoV-2-associated gut microbiome alteration; A new contributor to colorectal cancer pathogenesis.Pathol Res Pract2022;239:154131

[55] McNabney SM.Short chain fatty acids in the colon and peripheral tissues: a focus on butyrate, colon cancer, obesity and insulin resistance.Nutrients2017;9:1348

[56] Lo BC,Canals Hernaez D.IL-22 preserves gut epithelial integrity and promotes disease remission during chronic salmonella infection.J Immunol2019;202:956-65

[57] Maruyama D,Tian X.Regulation of lung immune tone by the gut-lung axis via dietary fiber, gut microbiota, and short-chain fatty acids.bioRxiv2023;In press:

[58] Cryan JF,Sandhu K,Dinan TG.The gut microbiome in neurological disorders.Lancet Neurol2020;19:179-94

[59] Hashimoto K.Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: the role of Epstein-Barr virus and the gut-brain axis.Mol Psychiatry2023;In press:

[60] Luo J,Jin F.Gut microbiota in antiviral strategy from bats to humans: a missing link in COVID-19.Sci China Life Sci2021;64:942-56

[61] Ghannoum MA,Bonomo RA,McCormick TS.A microbiome-driven approach to combating depression during the COVID-19 pandemic.Front Nutr2021;8:672390

[62] Nakov R,Snegarova V,Fox M.Increased prevalence of gastrointestinal symptoms and disorders of gut-brain interaction during the COVID-19 pandemic: an internet-based survey.Neurogastroenterol Motil2022;34:e14197

[63] Liu Q,Su Q.Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome.Gut2022;71:544-52